CRI market research report

Europe Home Blood Capillary Diagnostics Kits Market 2027

$2950 – $5250

The growth of the Europe home blood capillary diagnostics kits market is attributed due to the increase in the number of product approvals and the growing geriatric population.

SKU: MRFR220340 Category: Tag:

Description

Europe Home Blood Capillary Diagnostics Kits Market 2027

Market Overview
The growth of the Europe home blood capillary diagnostics kits market is attributed due to the increase in the number of product approvals and the growing geriatric population. Other factors such as the increase in chronic and infectious diseases are fuelling the Europe home blood capillary diagnostics kits market.

However, concerns regarding the risks associated with the process might hamper the market growth to some extent.
Capillary blood sampling, or drawing blood from a puncture on a finger, heel, or earlobe, is becoming more popular in medicine. It has various advantages over venous blood collection, such as being less intrusive, requiring less blood volume, and being rapid and simple to conduct.

An increase in the number of product approvals and an increase in chronic and infectious diseases are expected to be some of the major factors driving the market growth during the forecast period. Another factor that supplements the market growth is the increasing geriatric population in Europe. However, associated risks of capillary blood collection may hinder the market growth.

Market Segmentation
Based on component type, the Europe home blood capillary diagnostics kits market has been segmented into micro collection tubes, lancets, and others. The micro collection tubes segment is expected to be the largest and fastest-growing market throughout the study period. It is estimated to hold a market share of 45.58% in 2020, exhibiting a CAGR of 5.99% during the assessment period

Based on application, the Europe home blood capillary diagnostics kits market has been categorized into whole blood tests, plasma/serum protein tests, Comprehensive Metabolite Panel (CMP), liver panel/liver profile/Liver Function Tests (LFTs), blood glucose monitoring, blood gases testing and others. The blood glucose monitoring segment is expected to be the largest segment registering a market share of 27.1% in 2020. The blood glucose monitoring test is also the fastest-growing segment with a CAGR of 6.92% owing to factors such as the rising population of diabetes patients across Europe.

Regional Market
The Europe home blood capillary diagnostics kits market is segmented into Germany, France, the UK, Italy, Ireland, Netherlands, The Nordics, Spain, and the rest of Europe. Germany held the largest market share of USD 49.02 million in 2020 and is anticipated to dominate the Europe home blood capillary diagnostics kit market during the forecast period.

Blood can either be collected on filter paper or in capillary blood collection tubes with a serum separator additive. The Europe home blood capillary diagnostics kit market is anticipated to increase with a surge in the number of infectious diseases. Europe comprises a large population prone to infectious diseases. Chlamydia infection, campylobacteriosis, salmonellosis, gonorrhea, and tuberculosis are some of the most reported infectious diseases in Europe.

Major Players
The key competitors in the Europe Home Blood Capillary Diagnosis market are Neoteryx, LLC (Canada), Tasso Inc. (US), Becton, Dickinson, and Company, Hemaxis, Eldon Biologics A/S, Cerascreen, Seventh Sense Biosystems, Nature’s Way Products LLC, and others.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 2.2 RESEARCH OBJECTIVE 2.3 MARKET STRUCTURE 2.4 ASSUMPTIONS & LIMITATIONS 3 RESEARCH METHODOLOGY 3.1 DATA MINING 3.2 SECONDARY RESEARCH 3.3 PRIMARY RESEARCH 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 3.5 FORECASTING TECHNIQUES 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 3.6.1 BOTTOM-UP APPROACH 3.6.2 TOP-DOWN APPROACH 3.7 DATA TRIANGULATION 3.8 VALIDATION 4 MARKET DYNAMICS 4.1 OVERVIEW 4.2 DRIVERS 4.2.1 INCREASE IN THE NUMBER OF PRODUCT APPROVALS 4.2.2 GROWING GERIATRIC POPULATION 4.2.3 RISING CHRONIC AND INFECTIOUS DISEASES 4.3 RESTRAINTS 4.3.1 ASSOCIATED RISKS OF CAPILLARY BLOOD COLLECTION 4.4 OPPORTUNITIES 4.4.1 ADVANCEMENTS IN TECHNOLOGY 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION AND SALES 5.1.4 POST-SALES MONITORING 5.2 PORTER’S FIVE FORCES MODEL 5.2.1 BARGAINING POWER OF SUPPLIERS 5.2.2 BARGAINING POWER OF BUYERS 5.2.3 THREAT OF NEW ENTRANTS 5.2.4 THREAT OF SUBSTITUTES 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 ON EUROPE HOME BLOOD CAPILLARY DIAGNOSTICS KIT MARKET 5.3.1 IMPACT ON SUPPLY CHAIN 5.3.2 IMPACT ON EUROPEAN MARKET 5.3.3 IMPACT ON RESEARCH AND DEVELOPMENT 5.4 INDUSTRY TRENDS 5.5 REGULATORY ANALYSIS 5.6 REIMBURSEMENT SCENARIO 6 EUROPE HOME BLOOD CAPILLARY DIAGNOSTIC KITS MARKET, BY COMPONENT TYPE 6.1 OVERVIEW 6.2 MICRO COLLECTION TUBES 6.3 LANCETS 6.4 OTHERS 7 EUROPE HOME BLOOD CAPILLARY DIAGNOSTIC KITS MARKET, BY APPLICATION 7.1 OVERVIEW 7.2 BLOOD GLUCOSE MONITORING 7.3 BLOOD GASES TESTING 7.4 WHOLE BLOOD TEST 7.5 LIVER PANEL/LIVER PROFILE/LIVER FUNCTION TESTS (LFTS) 7.6 PLASMA SERUM/SERUM PROTEIN TEST 7.7 COMPREHENSIVE METABOLITE PANEL (CMP) 7.8 OTHERS 8 EUROPE HOME BLOOD CAPILLARY DIAGNOSTIC KITS MARKET, BY COUNTRY 8.1 OVERVIEW 8.2 GERMANY 8.3 UK 8.4 FRANCE 8.5 THE NORDICS 8.6 ITALY 8.7 NETHERLANDS 8.8 SPAIN 8.9 IRELAND 8.10 REST OF EUROPE 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 9.2 COMPETITIVE BENCHMARKING 9.3 MAJOR GROWTH STRATEGY IN THE EUROPE HOME BLOOD CAPILLARY DIAGNOSTIC KITS MARKET 9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE EUROPE HOME BLOOD CAPILLARY DIAGNOSTIC KITS MARKET 9.5 KEY DEVELOPMENT ANALYSIS 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 9.6.2 MERGER/ ACQUISITION 9.6.3 EXPANSION/ INVESTMENT 9.7 GO TO MARKET STRATEGY (GTM) 10 COMPANY PROFILES 10.1 TASSO, INC 10.1.1 COMPANY OVERVIEW 10.1.2 FINANCIAL OVERVIEW 10.1.3 PRODUCTS/SERVICES OFFERED 10.1.4 KEY DEVELOPMENTS 10.1.5 SWOT ANALYSIS 10.1.6 KEY STRATEGIES 10.2 NEOTERYX, LLC 10.2.1 COMPANY OVERVIEW 10.2.2 FINANCIAL OVERVIEW 10.2.3 PRODUCTS/SERVICES OFFERED 10.2.4 KEY DEVELOPMENTS 10.2.5 SWOT ANALYSIS 10.2.6 KEY STRATEGIES 10.3 BECTON, DICKINSON AND COMPANY 10.3.1 COMPANY OVERVIEW 10.3.2 FINANCIAL OVERVIEW 10.3.3 PRODUCTS/SERVICES OFFERED 10.3.4 KEY DEVELOPMENTS 10.3.5 SWOT ANALYSIS 10.3.6 KEY STRATEGIES 10.4 HEMAXIS 10.4.1 COMPANY OVERVIEW 10.4.2 FINANCIAL OVERVIEW 10.4.3 PRODUCTS/SERVICES OFFERED 10.4.4 KEY DEVELOPMENTS 10.4.5 SWOT ANALYSIS 10.4.6 KEY STRATEGIES 10.5 CERASCREEN GMBH 10.5.1 COMPANY OVERVIEW 10.5.2 FINANCIAL OVERVIEW 10.5.3 PRODUCTS/SERVICES OFFERED 10.5.4 KEY DEVELOPMENTS 10.5.5 SWOT ANALYSIS 10.5.6 KEY STRATEGIES 10.6 SEVENTH SENSE BIOSYSTEMS 10.6.1 COMPANY OVERVIEW 10.6.2 FINANCIAL OVERVIEW 10.6.3 PRODUCTS/SERVICES OFFERED 10.6.4 KEY DEVELOPMENTS 10.6.5 SWOT ANALYSIS 10.6.6 KEY STRATEGIES 10.7 NATURE’S WAY PRODUCTS, LLC 10.7.1 COMPANY OVERVIEW 10.7.2 FINANCIAL OVERVIEW 10.7.3 PRODUCTS/SERVICES OFFERED 10.7.4 KEY DEVELOPMENTS 10.7.5 SWOT ANALYSIS 10.7.6 KEY STRATEGIES 11 APPENDIX 11.1 REFERENCES 11.2 RELATED REPORTS

Companies Mentioned

Neoteryx, LLC (Canada), Tasso Inc. (US), Becton, Dickinson, and Company, Hemaxis, Eldon Biologics A/S, Cerascreen, Seventh Sense Biosystems, Nature’s Way Products LLC, and others.

Reviews

There are no reviews yet.

Be the first to review “Europe Home Blood Capillary Diagnostics Kits Market 2027”

Related products